A large unilateral basal cell carcinoma treated with Hedgehog inhibitor sonidegib: a case report
Basal cell carcinoma (BCC) is the most common non-melanoma skin cancer. BCCs are categorized into “easy-to-treat” and “difficult-to-treat” groups, with the latter including all BCCs that are challenging to manage due to technical, patient-related, or tumor-related factors, such as locally advanced...
Saved in:
Main Authors: | Maria Alessandra Mattioli, Valentina Benzecry, Giulia Murgia, Nerina Denaro, Angelo Valerio Marzano, Emanuela Passoni, Gianluca Nazzaro |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2024-11-01
|
Series: | Dermatology Reports |
Subjects: | |
Online Access: | https://www.pagepress.org/journals/dr/article/view/10152 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sarcoidosis-Like Reaction in Melanoma Patients Receiving Immunotherapy or Targeted Therapy
by: Giulia Murgia, et al.
Published: (2024-01-01) -
Defect size and surgical site are key predictors of surgical site infection risk in dermatologic surgery: A retrospective cohort study
by: Rawlings E. Lyle, MAS, et al.
Published: (2025-02-01) -
A Matching-Adjusted Indirect Comparison of Sonidegib and Vismodegib in Advanced Basal Cell Carcinoma
by: Dawn Odom, et al.
Published: (2017-01-01) -
Long-term control with immunotherapy and aggressive re-irradiation for basal cell carcinoma metastatic to the vertebra: A case report and literature review of rare osseous metastasis
by: Andrew R. Cunningham, et al.
Published: (2024-12-01) -
Atypical Presentation of Rapidly Progressive Cutaneous Metastases of Clear Cell Renal Carcinoma: A Case Report
by: Carmen Andrada Iliescu, et al.
Published: (2024-11-01)